Tilray Shares in Holding Pattern Ahead of Earnings Release

Investors are adopting a wait-and-see approach with Tilray Brands, Inc. as the cannabis company prepares to release its quarterly financial results. The stock concluded the 2025 trading year with minimal movement, a period of consolidation following significant corporate actions and amid broader sector volatility.

All eyes are on the upcoming earnings report, scheduled for release after the U.S. market closes on Thursday, January 8. This document will cover Tilray’s performance for the second quarter of its fiscal 2026 year and is widely viewed as the first major catalyst for the stock in the new calendar year.

Market consensus estimates currently anticipate the following figures:

• Revenue: Approximately $211 million
• Earnings Per Share (EPS): A projected loss in the range of -$0.17 to -$0.21

The primary focus for shareholders will be whether the company meets or surpasses the $211 million revenue target. Success here could provide a foundation for share price stability. Conversely, a miss may place immediate downward pressure on the stock. Analysts will also scrutinize whether recent cost-cutting initiatives and capital structure adjustments are translating into tangible balance sheet improvements.

Technical Landscape Post-Reverse Split

Tilray’s share price activity has been muted since the execution of a 1-for-10 reverse stock split on December 1, 2025. This corporate action reduced the number of outstanding shares from roughly 1.16 billion to 116 million. While such a move does not alter the company’s fundamental valuation, it is designed to adjust the stock's trading price, moving it out of the penny-stock range to appeal to a broader base of institutional investors, many of whom avoid equities priced below $5.

Should investors sell immediately? Or is it worth buying Tilray?

In the final session of 2025, the stock demonstrated limited volatility. It opened at $8.93, touched a daily low of $8.84 and a high of $9.25, before closing at $9.03—a marginal gain of 0.11%. The $9 level now holds technical significance as the market seeks a new equilibrium post-split.

The current price of $9.03 remains below the split-adjusted 50-day moving average, indicating that a longer-term cautious sentiment persists.

Analyst Sentiment and Key Price Levels

Recent analyst assessments from December paint a neutral picture. The consensus rating for Tilray stock is a "Hold." The average price target sits around $20, suggesting significant potential upside; however, this optimism is explicitly contingent on the company successfully achieving its fiscal 2026 objectives. In the near term, observers expect continued price fluctuation leading up to the earnings announcement.

From a chart perspective, two key levels are in focus for the initial trading days of 2026:

• Support: The December 31 daily low of $8.84 is considered a short-term floor. A sustained break below this level would signal weakening stability.
• Resistance: A climb above the December 31 high of $9.25 could indicate speculative positioning by traders ahead of the Q2 results.

The upcoming earnings report presents a clear test. In-line figures may allow the stock to solidify around $9 or attempt a modest advance, while any deviation from expectations is likely to be swiftly reflected in its share price.